Skip to Main Content

Paper Details

Anti-tumor effects of an ID antagonist with no observed acquired resistance.
NPJ Breast Cancer
9
2021
AGX51, ID, ID proteins, basic-HLH transcription factors, breast cancer, breast tumors, cancer, cancer cell, cancer cell lines, cancers, helix-loop-helix (HLH) transcriptional, mice, mouse, oxygen, paclitaxel, paclitaxel-resistant, sporadic colorectal neoplasia, tumor
Author NameAffiliation
Rajesh K SoniMemorial Sloan Kettering Cancer Center
Larry NortonMemorial Sloan Kettering Cancer Center
Larry NortonMemorial Sloan Kettering Cancer Center
Ronald C HendricksonMemorial Sloan Kettering Cancer Center
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center
Andrew J DannenbergWeill Cornell Medical College
Anna LasorellaInstitute for Cancer Genetics, Columbia University Medical Center
  • 1 - 8

Datasets

Release 1.2